Corporate Profile
| Company Name | Nichi-Iko Pharmaceutical Co., Ltd. |
|---|---|
| Head Quarters (Toyama) | 1-6-21 Sogawa, Toyama City, Toyama Prefecture, Japan |
| Head Quarters (Tokyo) | 5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan |
| Foundation | July 15 1965 |
| Capital | 23,360 million yen |
| Affiliated Banks | Hokuriku Bank, Mitsui Sumitomo Bank, Hokkoku Bank, Sumitomo Mitsui Trust Bank, Tokyo Mitsubishi UFJ, Development Bank of Japan |
| Fiscal Year | March |
| Stock Exchange listings | Tokyo Stock Exchange, First Section |
| Business Activities | Manufacturing, sales, distribution, export, import and related activities for various types of pharmaceuticals; Treatments for circulatory, digestive, respiratory, central and peripheral nervous systems and others; 1,226 items (as of March 31, 2020) |
| Employees | 1,954 (as of March 31, 2020, consolidated) |
| R&D Sites | Global Development Center [Toyama] |
| Production Sites | 10 manufacturing plants Hokkaido Plant (Antiseptics) Yamagata Plant (External) Saitama Plant (Oral Jelly, Eye Drop & Divided Liquid) Shizuoka Plant (Tablets, Capsules, Granules & Injections) Aichi Plant (Injections) Gifu Plant (Oral Drugs & Injections) Toyama Plant 1 (Tablets & Capsules) Canada Omega Plant（Injections） USA Raleigh Plant（Injections） USA Plattsburgh Plant（Compound） |
| Distribution centers | Nichi-Iko Distribution Center [Toyama] East Japan Distribution Center [Saitama] West Japan Distribution Center [Hyogo] Hokkaido Distribution Center [Hokkaido] |
| Branch Offices | Sapporo, Sendai, Kanto, Tokyo 1st & 2nd, Nagoya, Keiji-Hokuriku, Osaka, Hiroshima, Fukuoka |
| Overseas Subsidiaries |
Sagent Pharmaceuticals, Inc. [USA] Omega Laboratories, Ltd. [Canada] SterRx, LLC. [USA] NIXS Corporation [USA] Nichi-Iko（Thailand）Co., Ltd. [Thailand] |
| Subsidiaries (Head Office Site) |
Nichi-Iko Gifu Plant Co., Ltd. [Toyama] Elmed Co., Ltd. [Toyama] Yakuhan Pharmaceutical Co., Ltd. [Hokkaido] EMI Inc. [Osaka] Nichi-Iko Osaka Co., Ltd. [Osaka] |